Skip to main content

P3 Health Partners Inc. (PIIIW) Stock Forecast


Stock Price Forecast

Feb. 25, 2025


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading P3 Health Partners Inc. chart...

About the Company

A public–private partnership (PPP, 3P, or P3) is a long-term arrangement between a government and private sector institutions. Typically, it involves private capital financing government projects and services up-front, and then drawing revenues from taxpayers and/or users for profit over the course of the PPP contract. Public–private partnerships have been implemented in multiple countries and are primarily used for infrastructure projects. Although they are not compulsory, PPPs have been employed for building, equipping, operating and maintaining schools, hospitals, transport systems, and water and sewerage systems. Cooperation between private actors, corporations and governments has existed since the inception of sovereign states, notably for the purpose of tax collection and colonization. Contemporary "public–private partnerships" came into being around the end of the 20th century. They were aimed at increasing the private sector's involvement in public administration. They were seen by governments around the world as a method of financing new or refurbished public sector assets outside their balance sheet. While PPP financing comes from the private sector, these projects are always paid for either through taxes or by users of the service, or a mix of both. PPPs are structurally more expensive than publicly financed projects because of the private sector's higher cost of borrowing, resulting in users or taxpayers footing the bill for disproportionately high interest costs. PPPs also have high transaction costs. PPPs are controversial as funding tools, largely over concerns that public return on investment is lower than returns for the private funder. PPPs are closely related to concepts such as privatization and the contracting out of government services. The secrecy surrounding their financial details complexifies the process of evaluating whether PPPs have been successful. PPP advocates highlight the sharing of risk and the development of innovation, while critics decry their higher costs and issues of accountability. Evidence of PPP performance in terms of value for money and efficiency, for example, is mixed and often unavailable.

Exchange

Nasdaq

$379M

Total Revenue

None

Employees

$0M

Market Capitalization

None

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest News on P3 Health Partners Inc.

P3 Health Partners Inc. (NASDAQ:PIII) Q2 2025 Earnings Call Transcript

on MSN ago, source: Insider Monkey on MSN.com

Q2 2025 Earnings Call Transcript August 14, 2025 P3 Health Partners Inc. misses on earnings expectations. Reported EPS is $-6 ...

P3 Health Partners Inc (PIII) Q2 2025 Earnings Call Highlights: Navigating Challenges with ...

3d ago, source: Yahoo Finance

P3 Health Partners Inc (PIII) reports a mixed quarter with strategic renegotiations and operational enhancements amid declining membership and revenue.

P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates

3d ago, source: None

P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.23 per share versus the Zacks Consensus Estimate of a loss of $3.29. This compares to a loss of $7.5 per share a year ago. These ...

P3 Health Partners Announces Second Quarter 2025 Results

3d ago, source: Yahoo Finance

P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ...

P3 Health Partners Schedules Second Quarter 2025 Earnings Release and ...

18d ago, source: Business Wire

HENDERSON, Nev.-- (BUSINESS WIRE)-- P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company ...

P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call

17d ago, source: None

P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for ...

Similar Companies
Company Ticker 90 Days Forecast Market Cap. (USD M) P/E P/B
Agape ATP Corp ATPC Predict 62.94 None 2.69
DocGo Inc. DCGO Predict 143.26 15.49 0.46
EUDA Health Holdings Ltd EUDA Predict -127.18 -10.73 -17.47
EUDA Health Holdings Ltd EUDAW Predict 2.24 None -0.38
InnovAge Holding Corp. INNV Predict 522.74 -31.08 2.20
Kindly MD, Inc. KDLY Predict 83.21 None 54.42
Kindly MD, Inc. KDLYW Predict 2.33 None 0.67
Longduoduo Co Ltd LDDD Predict 165.79 None 166.12
LifeStance Health Group, Inc. LFST Predict 2116.58 -0.01 1.44
Kindly MD, Inc. NAKA Predict 103.57 None 11.55
Omada Health, Inc. OMDA Predict 1176.80 None 5.49
P3 Health Partners Inc. PIII Predict 0.00 -0.34 0.00
P3 Health Partners Inc. PIIIW Predict 0.00 None 0.00
Pennant Group, Inc. PNTG Predict 949.09 35.38 3.03
Privia Health Group, Inc. PRVA Predict 2928.08 197.30 4.29
Talkspace, Inc. TALK Predict 416.28 -81.85 3.67
Talkspace, Inc. TALKW Predict 37.16 None 0.32
U S PHYSICAL THERAPY INC /NV USPH Predict 1986.61 52.05 3.97
VSEE HEALTH, INC. VSEE Predict 0.01 -1.27 -1.90
VSEE HEALTH, INC. VSEEW Predict 0.00 None -0.09
GeneDx Holdings Corp. WGS Predict 2294.64 -19.26 8.91
GeneDx Holdings Corp. WGSWW Predict 7.23 None 0.03

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...